A Long-term Safety and Efficacy Study Evaluating CM512 in Atopic Dermatitis.

Abroad (travel likely)RecruitingPHASE2

Conditions

Atopic Dermatitis (AD)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Peking University People's Hospital, Beijing, Beijing Municipality, China
Contact: Study coordinator (Jianzhong Zhang) · rmzjz@126.com · 15545433012

Study leads

Jianzhong Zhang
Principal Investigator
Peking University People's Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis

Atopic Dermatitis (AD)

Abroad (travel likely)RecruitingPHASE2

Birmingham, United States · Hot Springs, United States

A Study Evaluating BFB759 in Moderate to Severe Atopic Dermatitis

Atopic Dermatitis (AD)

Abroad (travel likely)RecruitingPHASE2

Phoenix, United States · Phoenix, United States

A Double-Blind, Randomized, Vehicle-Controlled Phase 2 Study to Assess the Efficacy and Safety of GX-03 in Adult Subjects With Moderate to Severe Atopic Dermatitis (Eczema)

Eczema Atopic Dermatitis · Eczema · Atopic Dermatitis

Abroad (travel likely)RecruitingPHASE2

Irving, United States

A Clinical Study to Evaluate SM17 for Atopic Dermatitis

Atopic Dermatitis

Abroad (travel likely)RecruitingPHASE2

Beijing, China